Yuko Palesch to Adult
This is a "connection" page, showing publications Yuko Palesch has written about Adult.
Connection Strength
0.375
-
Twelve-Month Clinical and Quality-of-Life Outcomes in the Interventional Management of Stroke III Trial. Stroke. 2015 May; 46(5):1321-7.
Score: 0.034
-
Platelet-oriented inhibition in new TIA and minor ischemic stroke (POINT) trial: rationale and design. Int J Stroke. 2013 Aug; 8(6):479-83.
Score: 0.031
-
Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care. 2011 Dec; 15(3):559-76.
Score: 0.027
-
A randomized, placebo-controlled trial of buspirone for the treatment of anxiety in opioid-dependent individuals. Am J Addict. 2004 Jan-Feb; 13(1):53-63.
Score: 0.016
-
Anxiety and anger among family practice residents: a South Carolina family practice research consortium study. Acad Med. 2003 Jan; 78(1):69-79.
Score: 0.015
-
Blood pressure control and clinical outcomes in acute intracerebral haemorrhage: a preplanned pooled analysis of individual participant data. Lancet Neurol. 2019 09; 18(9):857-864.
Score: 0.012
-
Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III. J Neurotrauma. 2019 10 15; 36(20):2863-2871.
Score: 0.012
-
The Effect of Goal-Directed Therapy on Patient Morbidity and Mortality After Traumatic Brain Injury: Results From the Progesterone for the Treatment of Traumatic Brain Injury III Clinical Trial. Crit Care Med. 2019 05; 47(5):623-631.
Score: 0.011
-
Symptoms of depression in residents: a South Carolina Family Practice Research Consortium study. Acad Med. 1998 Dec; 73(12):1305-10.
Score: 0.011
-
Prehospital Intubation is Associated with Favorable Outcomes and Lower Mortality in ProTECT III. Prehosp Emerg Care. 2017 Sep-Oct; 21(5):539-544.
Score: 0.010
-
A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3). Int J Stroke. 2017 10; 12(8):896-905.
Score: 0.010
-
Very Early Administration of Progesterone Does Not Improve Neuropsychological Outcomes in Subjects with Moderate to Severe Traumatic Brain Injury. J Neurotrauma. 2017 01 01; 34(1):115-120.
Score: 0.009
-
Scientific Rationale for the Inclusion and Exclusion Criteria for Intravenous Alteplase in Acute Ischemic Stroke: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2016 Feb; 47(2):581-641.
Score: 0.009
-
Outcome Differences between Intra-Arterial Iso- and Low-Osmolality Iodinated Radiographic Contrast Media in the Interventional Management of Stroke III Trial. AJNR Am J Neuroradiol. 2015 Nov; 36(11):2074-81.
Score: 0.009
-
Recombinant tissue-type plasminogen activator plus eptifibatide versus recombinant tissue-type plasminogen activator alone in acute ischemic stroke: propensity score-matched post hoc analysis. Stroke. 2015 Feb; 46(2):461-4.
Score: 0.008
-
Very early administration of progesterone for acute traumatic brain injury. N Engl J Med. 2014 Dec 25; 371(26):2457-66.
Score: 0.008
-
Endovascular revascularization results in IMS III: intracranial ICA and M1 occlusions. J Neurointerv Surg. 2015 Nov; 7(11):795-802.
Score: 0.008
-
Evolution of practice during the Interventional Management of Stroke III Trial and implications for ongoing trials. Stroke. 2014 Dec; 45(12):3606-11.
Score: 0.008
-
Recanalization and clinical outcome of occlusion sites at baseline CT angiography in the Interventional Management of Stroke III trial. Radiology. 2014 Oct; 273(1):202-10.
Score: 0.008
-
Increased brain volume among good grade patients with intracerebral hemorrhage. Results from the Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) study. Neurocrit Care. 2014 Jun; 20(3):470-5.
Score: 0.008
-
Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
Score: 0.008
-
Time to angiographic reperfusion and clinical outcome after acute ischaemic stroke: an analysis of data from the Interventional Management of Stroke (IMS III) phase 3 trial. Lancet Neurol. 2014 Jun; 13(6):567-74.
Score: 0.008
-
Collaterals at angiography and outcomes in the Interventional Management of Stroke (IMS) III trial. Stroke. 2014 Mar; 45(3):759-64.
Score: 0.008
-
High dose deferoxamine in intracerebral hemorrhage (HI-DEF) trial: rationale, design, and methods. Neurocrit Care. 2013 Oct; 19(2):257-66.
Score: 0.008
-
High-dose albumin treatment for acute ischaemic stroke (ALIAS) Part 2: a randomised, double-blind, phase 3, placebo-controlled trial. Lancet Neurol. 2013 Nov; 12(11):1049-58.
Score: 0.008
-
Endovascular therapy after intravenous t-PA versus t-PA alone for stroke. N Engl J Med. 2013 Mar 07; 368(10):893-903.
Score: 0.007
-
Intramuscular versus intravenous therapy for prehospital status epilepticus. N Engl J Med. 2012 Feb 16; 366(7):591-600.
Score: 0.007
-
Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol. 2010 May; 67(5):570-6.
Score: 0.006
-
Methodology of the Interventional Management of Stroke III Trial. Int J Stroke. 2008 May; 3(2):130-7.
Score: 0.005
-
Lessons from adult stroke trials. Pediatr Neurol. 2006 Jun; 34(6):446-9.
Score: 0.005
-
Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004 Jun; 239(6):828-37; discussion 837-40.
Score: 0.004
-
Long-term follow-up of absence seizures. Neurology. 1983 Dec; 33(12):1590-5.
Score: 0.004
-
Age and alarm symptoms do not predict endoscopic findings among patients with dyspepsia: a multicentre database study. Gut. 2001 Jul; 49(1):29-34.
Score: 0.003
-
Polymorphic cytokine genotypes as markers of disease severity in adult periodontitis. J Clin Periodontol. 1999 Nov; 26(11):705-9.
Score: 0.003
-
Contribution of interleukin 1beta and KM loci to alopecia areata. Hum Hered. 1999 Mar; 49(2):85-9.
Score: 0.003
-
Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998 Dec; 115(6):1518-24.
Score: 0.003
-
Interleukin-1beta+3953 allele 2: association with disease status in adult periodontitis. J Clin Periodontol. 1998 Oct; 25(10):781-5.
Score: 0.003
-
The body mass index-mortality relationship in white and African American women. Obes Res. 1998 Jul; 6(4):268-77.
Score: 0.003
-
Geographic variation in the prevalence of Raynaud's phenomenon: a 5 region comparison. J Rheumatol. 1997 May; 24(5):879-89.
Score: 0.002
-
Pancreatic sphincter hypertension increases the risk of post-ERCP pancreatitis. Endoscopy. 1997 May; 29(4):252-7.
Score: 0.002
-
The effect of bupivacaine skull block on the hemodynamic response to craniotomy. Anesth Analg. 1996 Dec; 83(6):1256-61.
Score: 0.002
-
Digital vascular responses to cooling in subjects with cold sensitivity, primary Raynaud's phenomenon, or scleroderma spectrum disorders. J Rheumatol. 1996 Dec; 23(12):2068-78.
Score: 0.002
-
Physical and psychological health of family practice residents. Fam Med. 1995 Nov-Dec; 27(10):646-51.
Score: 0.002
-
Propranolol metabolism in normal subjects: association with sex steroid hormones. Clin Pharmacol Ther. 1994 Aug; 56(2):127-32.
Score: 0.002
-
Sex differences in declining cohort death rates from heart disease. Am J Public Health. 1982 Feb; 72(2):161-6.
Score: 0.001